For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, ...
Concordance and clinical impact of ER, PR, HER2 expression by local and central immunohistochemistry versus RT-PCR in HR+/HER2- early breast cancer (EBC): Results from the ADAPT trial. Rate of medical ...
Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...
Please provide your email address to receive an email when new articles are posted on . The Endocrine Self-Assessment Program In-Training Examination is a strong predictor of pass/fail outcomes on the ...
When these hormones become imbalanced, it can lead to the development of an endocrine disorder. “An endocrine disorder occurs when your body produces either too much or too little of a particular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results